ArticleThe European respiratory journal2023

Inhibition of MRTF activation as a clinically achievable anti-fibrotic mechanism for pirfenidone.

Hsiao-Yen Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.